AG
THC icon

Aperio Group’s Tenet Healthcare THC Stock Holding History

Aperio Group’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$2.15M Sell
53,972
-897
-2% -$28.9K 0.01% 1201
2020
Q3 		$1.34M Sell
54,869
-3,804
-6% -$97.2K ﹤0.01% 1299
2020
Q2 		$1.06M Sell
58,673
-25,109
-30% -$495K ﹤0.01% 1386
2020
Q1 		$1.21M Buy
83,782
+5,404
+7% +$155K 0.01% 1230
2019
Q4 		$2.98M Buy
78,378
+3,447
+5% +$103K 0.01% 917
2019
Q3 		$1.66M Buy
74,931
+14,333
+24% +$305K 0.01% 1138
2019
Q2 		$1.25M Buy
60,598
+4,993
+9% +$115K 0.01% 1287
2019
Q1 		$1.6M Buy
55,605
+493
+0.9% +$12.2K 0.01% 1133
2018
Q4 		$945K Buy
55,112
+2,452
+5% +$59.3K ﹤0.01% 1341
2018
Q3 		$1.5M Sell
52,660
-629
-1% -$20.8K 0.01% 1183
2018
Q2 		$1.79M Sell
53,289
-4,558
-8% -$142K 0.01% 1083
2018
Q1 		$1.4M Buy
57,847
+14,661
+34% +$292K 0.01% 1146
2017
Q4 		$655K Sell
43,186
-22,608
-34% -$318K ﹤0.01% 1573
2017
Q3 		$1.08M Sell
65,794
-15,482
-19% -$263K 0.01% 1219
2017
Q2 		$1.57M Buy
81,276
+32,708
+67% +$571K 0.01% 998
2017
Q1 		$860K Buy
48,568
+14,493
+43% +$269K 0.01% 1236
2016
Q4 		$506K Sell
34,075
-6,643
-16% -$119K ﹤0.01% 1509
2016
Q3 		$923K Sell
40,718
-4,535
-10% -$118K 0.01% 1140
2016
Q2 		$1.25M Buy
45,253
+13,184
+41% +$390K 0.01% 977
2016
Q1 		$928K Buy
32,069
+3,039
+10% +$79.1K 0.01% 1077
2015
Q4 		$880K Buy
29,030
+10,359
+55% +$340K 0.01% 1071
2015
Q3 		$689K Buy
18,671
+4,399
+31% +$227K 0.01% 1135
2015
Q2 		$826K Buy
14,272
+2,115
+17% +$108K 0.01% 1069
2015
Q1 		$602K Sell
12,157
-350
-3% -$16.4K 0.01% 1173
2014
Q4 		$634K Sell
12,507
-1,132
-8% -$59.2K 0.01% 1102
2014
Q3 		$810K Buy
13,639
+801
+6% +$44.7K 0.01% 932
2014
Q2 		$603K Buy
12,838
+5,032
+64% +$227K 0.01% 1044
2014
Q1 		$334K Buy
+7,806
New +$344K ﹤0.01% 1551
2013
Q4 		– Sell
-8,543
Closed -$372K – 1504
2013
Q3 		$352K Buy
8,543
+29
+0.3% +$1.21K 0.01% 1325
2013
Q2 		$392K Buy
+8,514
New +$381K 0.01% 1143

Other funds holding THC

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aperio Group's THC Position: Q4 2020 in Review

Aperio Group reduced its Tenet Healthcare (THC) stake by 1.6% in Q4 2020, selling an estimated $28.9K and leaving 53,972 shares worth $2.15M. The position accounts for 0.01% of the portfolio, ranked #1201.

Aperio Group first reported a position in THC in Q2 2013 and has held it in 30 quarters since. The position peaked at $2.98M in Q4 2019. 278 funds tracked by Wall St. Rank hold THC as of Q4 2020.

  • Aperio Group held 53,972 shares of Tenet Healthcare worth $2.15M as of Q4 2020.
  • Aperio Group sold 897 Tenet Healthcare shares in Q4 2020, an estimated $28.9K.
  • Tenet Healthcare made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1201 holding.
  • Aperio Group first reported a position in Tenet Healthcare in Q2 2013 and has held it in 30 quarters since.
  • Aperio Group's Tenet Healthcare position peaked at $2.98M in Q4 2019.
  • 278 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.